当前位置:首页 - 行情中心 - 热景生物(688068) - 财务分析 - 现金流量表

热景生物

(688068)

  

流通市值:168.99亿  总市值:168.99亿
流通股本:9270.79万   总股本:9270.79万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金198,780,625.9596,774,269.5465,918,315.74361,466,766.89
  收到的税费返还216,839.07185,045.2613,032,732.4212,649,820.34
  收到其他与经营活动有关的现金42,759,621.7218,398,118.4527,127,689.966,612,535.17
  经营活动现金流入小计241,757,086.74115,357,433.21506,078,738.12380,729,122.4
  购买商品、接受劳务支付的现金51,515,581.1724,551,905.05175,870,780.41139,319,747.03
  支付给职工以及为职工支付的现金100,457,953.1856,018,236.06218,397,358.65152,342,456.67
  支付的各项税费7,823,025.083,270,560.9821,422,611.6616,398,060.35
  支付其他与经营活动有关的现金64,590,263.9441,374,559.03127,550,568.6782,243,846.91
  经营活动现金流出小计224,386,823.37125,215,261.12543,241,319.39390,304,110.96
  经营活动产生的现金流量净额17,370,263.37-9,857,827.91-37,162,581.27-9,574,988.56
二、投资活动产生的现金流量:
  收回投资收到的现金2,736,530,998.192,296,895,852.991,360,405,154.34179,687,953.82
  取得投资收益收到的现金12,854,100.9558,754,178.4738,742,329.364,846,031.17
  处置固定资产、无形资产和其他长期资产收回的现金净额685,974.22-1,187,406.131,106,000
  处置子公司及其他营业单位收到的现金净额3,000,000---
  收到的其他与投资活动有关的现金---321,248.66
  投资活动现金流入小计2,753,071,073.362,355,650,031.461,400,334,889.83185,961,233.65
  购建固定资产、无形资产和其他长期资产支付的现金5,434,457.63,582,27451,407,210.254,277,882.37
  投资支付的现金2,832,757,589.262,412,278,663.011,230,198,889.55258,202,611.89
  支付其他与投资活动有关的现金--7,893,981.3415,433.54
  投资活动现金流出小计2,838,192,046.862,415,860,937.011,289,500,081.09312,495,927.8
  投资活动产生的现金流量净额-85,120,973.5-60,210,905.55110,834,808.74-126,534,694.15
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,524,377.28-4,152,727.0647,016,135.57
  其中:子公司吸收少数股东投资收到的现金--1,000,0001,000,000
  取得借款收到的现金50,000,00050,000,000--
  收到其他与筹资活动有关的现金--41,863,408.51-
  筹资活动现金流入小计53,524,377.2850,000,00046,016,135.5747,016,135.57
  分配股利、利润或偿付利息支付的现金518,750231,25017,344,04117,344,041
  支付其他与筹资活动有关的现金72,380,847.4371,429,915.53108,152,933.2797,040,043.92
  筹资活动现金流出小计72,899,597.4371,661,165.53125,496,974.27114,384,084.92
  筹资活动产生的现金流量净额-19,375,220.15-21,661,165.53-79,480,838.7-67,367,949.35
四、汇率变动对现金及现金等价物的影响898,469.53730,621.52-154,032.41104,833
五、现金及现金等价物净增加额-86,227,460.75-90,999,277.47-5,962,643.64-203,372,799.06
  加:期初现金及现金等价物余额270,142,930.21270,142,930.21276,105,573.85276,112,073.85
  期末现金及现金等价物余额183,915,469.46179,143,652.74270,142,930.2172,739,274.79
补充资料:
  净利润-84,971,244.51--195,938,654.35-
  资产减值准备21,105.85-83,123,913.7-
  固定资产和投资性房地产折旧37,010,133.71-82,272,962.74-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧37,010,133.71-82,272,962.74-
  无形资产摊销1,912,308.02-3,771,954.72-
  长期待摊费用摊销3,922,214-14,054,850.62-
  处置固定资产、无形资产和其他长期资产的损失-601,429.66-1,632,972.55-
  固定资产报废损失--1,136,422.37-
  公允价值变动损失46,822,376.48--2,493,695.02-
  财务费用-88,490.95-557,223.82-
  投资损失-20,342,884.41-11,857,198.21-
  递延所得税-6,521,173.52-7,731,053.59-
  其中:递延所得税资产减少-6,521,619.59-7,731,053.59-
    递延所得税负债增加446.07---
  存货的减少12,481,240.94-47,590,128.77-
  经营性应收项目的减少3,096,453.12--77,157,398.94-
  经营性应付项目的增加13,391,465.9-3,306,195-
  其他7,739,883.29--24,343,732.05-
  现金的期末余额183,915,469.46-270,142,930.21-
  减:现金的期初余额270,142,930.21-276,105,573.85-
  现金及现金等价物的净增加额-86,227,460.75--5,962,643.64-
公告日期2025-08-302025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑